Avid Bioservices Inc (CDMO)
8.34
+0.13
(+1.58%)
USD |
NASDAQ |
May 03, 11:45
Avid Bioservices Cash from Investing (TTM): -51.17M for Jan. 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
January 31, 2024 | -51.17M |
October 31, 2023 | -57.98M |
July 31, 2023 | -84.92M |
April 30, 2023 | -77.64M |
January 31, 2023 | -77.15M |
October 31, 2022 | -85.86M |
July 31, 2022 | -59.08M |
April 30, 2022 | -56.41M |
January 31, 2022 | -35.99M |
October 31, 2021 | -18.71M |
July 31, 2021 | -13.57M |
April 30, 2021 | -9.864M |
January 31, 2021 | -6.504M |
October 31, 2020 | -5.807M |
July 31, 2020 | -4.263M |
April 30, 2020 | -3.812M |
January 31, 2020 | -3.233M |
October 31, 2019 | -1.995M |
July 31, 2019 | 1.698M |
April 30, 2019 | 4.544M |
January 31, 2019 | 6.103M |
October 31, 2018 | 6.57M |
July 31, 2018 | 2.418M |
April 30, 2018 | -0.793M |
January 31, 2018 | -2.764M |
Date | Value |
---|---|
October 31, 2017 | -3.802M |
July 31, 2017 | -3.087M |
April 30, 2017 | -3.059M |
January 31, 2017 | -3.747M |
October 31, 2016 | -5.782M |
July 31, 2016 | -8.462M |
April 30, 2016 | -8.791M |
January 31, 2016 | -12.27M |
October 31, 2015 | -10.99M |
July 31, 2015 | -8.32M |
April 30, 2015 | -8.449M |
January 31, 2015 | -4.423M |
October 31, 2014 | -2.959M |
July 31, 2014 | -3.105M |
April 30, 2014 | -2.522M |
January 31, 2014 | -1.775M |
October 31, 2013 | -1.334M |
July 31, 2013 | -0.636M |
April 30, 2013 | -0.751M |
January 31, 2013 | -0.843M |
October 31, 2012 | -0.804M |
July 31, 2012 | -1.204M |
April 30, 2012 | -1.171M |
January 31, 2012 | -1.38M |
October 31, 2011 | -1.475M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-85.86M
Minimum
Oct 2022
1.698M
Maximum
Jul 2019
-34.33M
Average
-18.71M
Median
Oct 2021
Cash from Investing (TTM) Benchmarks
Emergent BioSolutions Inc | 212.30M |
Creative Medical Technology Holdings Inc | 3.445M |
Viking Therapeutics Inc | -641.08M |
Stereotaxis Inc | 19.76M |
MAIA Biotechnology Inc | -- |